Incyte INCY Milestone and contract revenues — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Incyte in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Incyte's milestone and contract revenues — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Incyte's milestone and contract revenues — total revenues?
- Incyte (INCY) reported milestone and contract revenues — total revenues of $17M in Q1 2026.
- What is the long-term trend for Incyte's milestone and contract revenues — total revenues?
- Over 4 years (2021 to 2025), Incyte's milestone and contract revenues — total revenues has grown at a 12.1% compound annual growth rate (CAGR), from $95M to $150M.
- What does milestone and contract revenues — total revenues mean?
- This metric represents the portion of total revenue derived from contractual milestone payments, such as those triggered by successful clinical trial outcomes, regulatory approvals, or commercial sales thresholds achieved by partners. It reflects the company's ability to monetize its intellectual property through strategic licensing and collaboration agreements. These payments are often non-recurring and can cause significant fluctuations in top-line performance based on the timing of development milestones.